Krystal Biotech Earnings
NASDAQ: KRYSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Mon, Nov 2, 2026
Fiscal period
Sep/2026
EPS estimate
$1.91
Krystal Biotech earnings summary
Krystal Biotech is scheduled to report Sep/2026 earnings on Nov 2, 2026, with analysts expecting EPS of $1.91. In its most recent report on Aug 3, 2026 (Q2 2026), KRYS posted EPS of $1.79. Revenue for the quarter was $119.2 million.
Quarterly EPS is up 38.8% from the same quarter a year earlier. Across the last 16 reports, KRYS shares moved an average of 4.8% (in either direction) in the first trading session after results, rising 12 times and falling 4 times.
Summary generated from market data by MetaCap's automated system. Methodology
KRYS earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 3, 2026 | — | $1.79 | — | +1.8% |
| May 4, 2026 | — | $1.83 | — | +0.2% |
| Feb 17, 2026 | — | $1.69 | — | +5.3% |
| Nov 3, 2025 | — | $2.66 | — | +4.2% |
| Aug 4, 2025 | — | $1.29 | — | +8.4% |
| May 6, 2025 | — | $1.20 | — | -1.2% |
| Feb 19, 2025 | — | $1.53 | — | -4.6% |
| Nov 4, 2024 | — | $0.91 | — | -14.5% |
| Aug 5, 2024 | — | $0.53 | — | +5.6% |
| May 6, 2024 | — | $0.03 | — | +6.0% |
| Feb 26, 2024 | — | $0.61 | — | +2.4% |
| Nov 6, 2023 | — | $2.79 | — | +5.7% |
| Aug 7, 2023 | — | $-1.25 | — | +0.4% |
| May 8, 2023 | — | $-1.76 | — | +9.0% |
| Feb 27, 2023 | — | $-1.23 | — | -7.4% |
| Nov 7, 2022 | — | $-1.17 | — | +1.0% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.